Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $0.52, but opened at $0.50. Elite Pharmaceuticals shares last traded at $0.50, with a volume of 282,520 shares trading hands.
Elite Pharmaceuticals Stock Up 1.7%
The company's fifty day simple moving average is $0.58 and its two-hundred day simple moving average is $0.51. The company has a current ratio of 4.88, a quick ratio of 3.50 and a debt-to-equity ratio of 0.08.
Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) last issued its quarterly earnings data on Monday, June 30th. The specialty pharmaceutical company reported $0.01 earnings per share for the quarter. The firm had revenue of $32.00 million for the quarter. Elite Pharmaceuticals had a negative net margin of 5.13% and a positive return on equity of 3.96%.
Elite Pharmaceuticals Company Profile
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
